HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.

Abstract
In placental malaria (PM), sequestration of infected erythrocytes in the placenta is mediated by an interaction between VAR2CSA, a Plasmodium falciparum protein expressed on erythrocytes, and chondroitin sulfate A (CSA) on syncytiotrophoblasts. Recent works have identified ID1-DBL2Xb as the minimal CSA-binding region within VAR2CSA able to induce strong protective immunity, making it the leading candidate for the development of a vaccine against PM. Assessing the existence of population differences in the distribution of ID1-DBL2Xb polymorphisms is of paramount importance to determine whether geographic diversity must be considered when designing a candidate vaccine based on this fragment. In this study, we examined patterns of sequence variation of ID1-DBL2Xb in a large collection of P. falciparum field isolates (n=247) from different malaria-endemic areas, including Africa (Benin, Senegal, Cameroon and Madagascar), Asia (Cambodia), Oceania (Papua New Guinea), and Latin America (Peru). Detection of variants and estimation of their allele frequencies were performed using next-generation sequencing of DNA pools. A considerable amount of variation was detected along the whole gene segment, suggesting that several allelic variants may need to be included in a candidate vaccine to achieve broad population coverage. However, most sequence variants were common and extensively shared among worldwide parasite populations, demonstrating long term persistence of those polymorphisms, probably maintained through balancing selection. Therefore, a vaccine mixture including such stable antigen variants will be putatively applicable and efficacious in all world regions where malaria occurs. Despite similarity in ID1-DBL2Xb allele repertoire across geographic areas, several peaks of strong population differentiation were observed at specific polymorphic loci, pointing out putative targets of humoral immunity subject to positive immune selection.
AuthorsBita Bordbar, Nicaise Tuikue Ndam, Emmanuelle Renard, Sayeh Jafari-Guemouri, Livingstone Tavul, Charlie Jennison, Sédami Gnidehou, Rachida Tahar, Dionicia Gamboa, Jorge Bendezu, Didier Menard, Alyssa E Barry, Philippe Deloron, Audrey Sabbagh
JournalInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases (Infect Genet Evol) Vol. 25 Pg. 81-92 (Jul 2014) ISSN: 1567-7257 [Electronic] Netherlands
PMID24768682 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • Antigens, Protozoan
  • DNA, Protozoan
  • VAR2CSA protein, Plasmodium falciparum
  • Viral Vaccines
Topics
  • Adolescent
  • Adult
  • Antigenic Variation (immunology)
  • Antigens, Protozoan (genetics, immunology)
  • DNA, Protozoan (genetics)
  • Female
  • Gene Frequency
  • Genetic Variation
  • Humans
  • Malaria, Falciparum (epidemiology, immunology, parasitology)
  • Phylogeography
  • Placenta (immunology, parasitology)
  • Plasmodium falciparum (classification, immunology, isolation & purification, metabolism)
  • Pregnancy
  • Pregnancy Complications, Parasitic (immunology, parasitology)
  • Sequence Analysis, DNA
  • Viral Vaccines (genetics, immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: